IP Library Patent Application 16691247
Patent Application
App. No. 16/691,247

SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/691,247
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (14)

1 .- 10 . (canceled)

11 . A method comprising:

high throughput sequencing a nucleic acid sequence; and

detecting a methylation state of a site in said nucleic acid sequence, wherein said nucleic acid sequence comprises a hydroxymethylated base.

12 . The method of claim 11 , wherein said nucleic acid sequence is a mammalian nucleic acid sequence.

13 . The method of claim 11 , wherein said nucleic acid sequence is obtained from a eukaryotic organism

14 . The method of claim 11 , wherein said nucleic acid sequence is not obtained from a bacteriophage.

15 . The method of claim 11 , wherein said nucleic acid sequence is of an extracellular fluid sample.

16 . The method of claim 11 , further comprising isolating said nucleic acid sequence from a sample.

17 . The method of claim 11 , further comprising obtaining said nucleic acid sequence.

18 . The method of claim 11 , further comprising associating a label with said site.

19 . The method of claim 11 , wherein said site comprises a genomic region.

20 . The method of claim 11 , wherein said nucleic acid sequence is from a subject in need thereof.

21 . The method of claim 11 , wherein said nucleic acid sequence is from a subject having or suspected of having cancer.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 053266/0148 →
MERGER Recorded Jul 21, 2020
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 053266/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 053266/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 053266/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 053266/0191 →